BROOKE MACKS: Open Payments
NPI 1578030243 · WESTFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 39 payments from 16 companies in 2025. Trend: 2023 $1,168 · 2024 $821 · 2025 $866
Food & beverage: $780Education: $85
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $120 |
| Regeneron Healthcare Solutions, Inc. | 3 | $119 |
| ABBVIE INC. | 7 | $108 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $73 |
| UCB, Inc. | 3 | $71 |
| Amgen Inc. | 4 | $64 |
| Janssen Biotech, Inc. | 3 | $56 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $55 |
| Lilly USA, LLC | 2 | $41 |
| LEO Pharma Inc. | 2 | $37 |
Products named: Opzelura, DUPIXENT, SKYRIZI, Bimzelx, OTEZLA, TREMFYA, Cabtreo, EBGLYSS.
Industry payments across NJ — which companies pay providers there.
